The pathophysiological basis of obesity-associated T2D is closely linked to insulin resistance (IR) and a persistent, low-grade inflammatory state originating in visceral adipose tissue (VAT), which progressively affects other insulin-sensitive organs including liver and skeletal muscle (28). The gene discussed is INS; the disease is obesity disorder.